Author

Louise Pritchett

Novartis (Switzerland)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

Alexander Geisel· 1 shared Björn Fröhlich· 1 shared Carsten HopfiD· 1 shared Christian Graf· 1 shared Mélanie Verneret· 1 shared S. SchmidtiD· 1 shared Thomas EnzleiniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Alexander Geisel

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Label-free Assessment of Complement-Dependent Cytotoxicity of Therapeutic Antibodies via a Whole-Cell MALDI Mass Spectrometry Bioassay

S. Schmidt, Alexander Geisel, Thomas Enzlein, Björn Fröhlich, Louise Pritchett, Mélanie Verneret, Christian Graf, Carsten Hopf

This study develops a label-free MALDI-TOF mass spectrometry bioassay to assess complement-dependent cytotoxicity of Rituximab, identifying metabolite markers and demonstrating robust concentration-response characteristics.

Scientific Reports · Sep 13, 2024Peer-reviewedBiochemistry